Skip to main content
logo
Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
5.25
-0.41 (-7.24%)
At close: Jul 24, 2026, 4:00 PM EDT
5.30
+0.05 (0.95%)
After-hours: Jul 24, 2026, 5:23 PM EDT

Edesa Biotech Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Income
-9.78-7.91-7.01-9.22-18.37-23.68
Net Income
-9.29-7.19-6.17-8.37-17.55-13.34
Earnings Per Share
-1.34-1.27-1.93-2.72-5.46-7.07
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
1010.791.045.367.097.84
Total Debt
000.020.090.020.1
Net Cash (Debt)
1010.791.025.277.077.74
Net Cash Growth
-28.01%960.70%-80.68%-25.52%-8.63%9.79%
Net Cash Per Share
1.311.900.321.713.074.45

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-4.21-7.32-4.89-6.64-12.28-13.66
Capital Expenditures
-----0.01-0.01
Free Cash Flow
-4.21-7.32-4.89-6.64-12.28-13.67
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Forward PE
-0.880.880.8856.67-